COVID-19: How neuro-ophthalmology is acclimating in the pandemic era

Article

Andrew G. Lee, MD, chair of the Blanton Eye Institute, Houston Methodist Hospital, in Houston, Texas, shares how operations within the neuro-ophthalmology field have had to adapt amid the coronavirus outbreak as well as how he and staff are practicing social distancing with in-person patient visits.
 

See more coronavirus coverage here 

 

Related Videos
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
Understanding fluid dynamics in wet macular degeneration
YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME
What are you most excited about in the field of retina? Tunde Peto, MD, PhD weighs in
Leveraging noninvasive ophthalmic imaging for patients with Alzheimer disease and analyzing UK Biobank data
EURETINA 2022: Leadership discusses what to expect, outlines Women in Retina program
DAVIO trial update: 12-month safety results indicate no serious adverse events, reduced treatment burden
Phase 4 Paladin finds fluocinolone to be safe, effective in patients with diabetic macular edema
© 2024 MJH Life Sciences

All rights reserved.